Cite

HARVARD Citation

    Kampmann, C. et al. (2014). Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment. Orphanet journal of rare diseases. 9 (1), pp. 1-7. [Online]. 
  
Back to record